Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Hoffmann

Showing results (151-160 of 312) with videos related to

Pageof 32
Sort By:
The Journal of Applied Laboratory Medicine|March 3, 2026
Estimation of Sex- and Age-Specific Reference Values for Serum Creatinine Using Three Indirect Methods in a Multicenter SettingAnne Meyer, Oana R Oprea, Robert Müller, et al.
Scientific Reports|February 2, 2024
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2Markus Hoffmann, Lina-Liv Willruth, Alexander Dietrich, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2Markus Hoffmann, Lina-Liv Willruth, Alexander Dietrich, et al.
Journal of Virology|April 6, 2026
Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4Nianzhen Chen, Hannah Kleine-Weber, Khaled Alkharsah, et al.
International Journal of Oncology|January 19, 2008
Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancerJan Bernd Weise, Katalin Csiszar, Stefan Gottschlich, et al.
The Lancet. Infectious Diseases|March 1, 2025
Host cell entry and neutralisation sensitivity of the emerging SARS-CoV-2 variant LP.8.1Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Cellular & Molecular Immunology|August 24, 2021
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccinationSwantje I Hammerschmidt, Berislav Bosnjak, Günter Bernhardt, et al.
European Journal of Immunology|April 9, 2024
Diversification of the VH3-53 immunoglobulin gene segment by somatic hypermutation results in neutralization of SARS-CoV-2 virus variantsMatthias Bruhn, Maureen Obara, Abdus Salam, et al.
International Journal of Molecular Sciences|October 13, 2021
The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 InfectionNadine Krüger, Cheila Rocha, Sandra Runft, et al.
The Lancet. Infectious Diseases|January 9, 2023
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineagePrerna Arora, Anne Cossmann, Sebastian R Schulz, et al.
Pageof 32

Showing results (151-160 of 312) with videos related to

Sort By:
Pageof 32
The Journal of Applied Laboratory Medicine|March 3, 2026
Estimation of Sex- and Age-Specific Reference Values for Serum Creatinine Using Three Indirect Methods in a Multicenter SettingAnne Meyer, Oana R Oprea, Robert Müller, et al.
Scientific Reports|February 2, 2024
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2Markus Hoffmann, Lina-Liv Willruth, Alexander Dietrich, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2Markus Hoffmann, Lina-Liv Willruth, Alexander Dietrich, et al.
Journal of Virology|April 6, 2026
Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4Nianzhen Chen, Hannah Kleine-Weber, Khaled Alkharsah, et al.
International Journal of Oncology|January 19, 2008
Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancerJan Bernd Weise, Katalin Csiszar, Stefan Gottschlich, et al.
The Lancet. Infectious Diseases|March 1, 2025
Host cell entry and neutralisation sensitivity of the emerging SARS-CoV-2 variant LP.8.1Lu Zhang, Amy Kempf, Inga Nehlmeier, et al.
Cellular & Molecular Immunology|August 24, 2021
Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccinationSwantje I Hammerschmidt, Berislav Bosnjak, Günter Bernhardt, et al.
European Journal of Immunology|April 9, 2024
Diversification of the VH3-53 immunoglobulin gene segment by somatic hypermutation results in neutralization of SARS-CoV-2 virus variantsMatthias Bruhn, Maureen Obara, Abdus Salam, et al.
International Journal of Molecular Sciences|October 13, 2021
The Upper Respiratory Tract of Felids Is Highly Susceptible to SARS-CoV-2 InfectionNadine Krüger, Cheila Rocha, Sandra Runft, et al.
The Lancet. Infectious Diseases|January 9, 2023
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineagePrerna Arora, Anne Cossmann, Sebastian R Schulz, et al.
Pageof 32